Immune Response deal

IMNR (Carlsbad, Calif.) and Rhone-Poulenc Rorer agreed to invest an additional $5 million each in Immunization Products Ltd., the companies’ HIV joint venture.

Following the investment, the companies will have contributed $55 million to the venture, with additional capital requirements still anticipated. The companies have completed Phase II/III studies and are planning a Phase III trial. ...